BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31660579)

  • 1. Moderate-to-strong expression of FGFR3 and TP53 alterations in a subpopulation of choroid plexus tumors.
    Granberg KJ; Raita A; Lehtinen B; Tiihonen AM; Kesseli J; Annala M; Rodriguez-Martinez A; Nordfors K; Zhang W; Visakorpi T; Nykter M; Haapasalo H
    Histol Histopathol; 2020 Jul; 35(7):673-680. PubMed ID: 31660579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.
    Lehtinen B; Raita A; Kesseli J; Annala M; Nordfors K; Yli-Harja O; Zhang W; Visakorpi T; Nykter M; Haapasalo H; Granberg KJ
    BMC Cancer; 2017 May; 17(1):310. PubMed ID: 28468611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
    Granberg KJ; Annala M; Lehtinen B; Kesseli J; Haapasalo J; Ruusuvuori P; Yli-Harja O; Visakorpi T; Haapasalo H; Nykter M; Zhang W
    Neuro Oncol; 2017 Sep; 19(9):1206-1216. PubMed ID: 28379477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 expression in choroid plexus neoplasms: an immunohistochemical study.
    Jay V; Ho M; Chan F; Malkin D
    Arch Pathol Lab Med; 1996 Nov; 120(11):1061-5. PubMed ID: 12049110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
    Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
    Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin receptor expression in normal and neoplastic choroid plexus.
    Beschorner R; Psaras T; Meyermann R; Bremer J; Schmidt T; Mittelbronn M; Schittenhelm J
    Clin Neuropathol; 2011; 30(1):33-40. PubMed ID: 21176716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
    Tabori U; Shlien A; Baskin B; Levitt S; Ray P; Alon N; Hawkins C; Bouffet E; Pienkowska M; Lafay-Cousin L; Gozali A; Zhukova N; Shane L; Gonzalez I; Finlay J; Malkin D
    J Clin Oncol; 2010 Apr; 28(12):1995-2001. PubMed ID: 20308654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of TP53 expression in immortalized choroid plexus epithelial cells results in increased resistance to anticancer agents.
    Krzyzankova M; Mertsch S; Koos B; Jeibmann A; Kruse A; Kordes U; Frühwald MC; Wolff JE; Paulus W; Hasselblatt M
    J Neurooncol; 2012 Sep; 109(3):449-55. PubMed ID: 22763759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive identification of
    Gu W; Yang J; Wang Y; Xu J; Wang X; Du F; Hu X; Guo H; Song C; Tao R; Zhang X
    Am J Cancer Res; 2021; 11(8):3893-3906. PubMed ID: 34522456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations.
    Murugesan K; Necchi A; Burn TC; Gjoerup O; Greenstein R; Krook M; López JA; Montesion M; Nimeiri H; Parikh AR; Roychowdhury S; Schwemmers S; Silverman IM; Vogel A
    ESMO Open; 2022 Dec; 7(6):100641. PubMed ID: 36462464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.
    Pienkowska M; Choufani S; Turinsky AL; Guha T; Merino DM; Novokmet A; Brudno M; Weksberg R; Shlien A; Hawkins C; Bouffet E; Tabori U; Gilbertson RJ; Finlay JL; Jabado N; Thomas C; Sill M; Capper D; Hasselblatt M; Malkin D
    Clin Epigenetics; 2019 Aug; 11(1):117. PubMed ID: 31409384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach.
    Hasselblatt M; Böhm C; Tatenhorst L; Dinh V; Newrzella D; Keyvani K; Jeibmann A; Buerger H; Rickert CH; Paulus W
    Am J Surg Pathol; 2006 Jan; 30(1):66-74. PubMed ID: 16330944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.
    Figarella-Branger D; Lepidi H; Poncet C; Gambarelli D; Bianco N; Rougon G; Pellissier JF
    Acta Neuropathol; 1995; 89(3):248-57. PubMed ID: 7754745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
    Lassman AB; Sepúlveda-Sánchez JM; Cloughesy TF; Gil-Gil MJ; Puduvalli VK; Raizer JJ; De Vos FYF; Wen PY; Butowski NA; Clement PMJ; Groves MD; Belda-Iniesta C; Giglio P; Soifer HS; Rowsey S; Xu C; Avogadri F; Wei G; Moran S; Roth P
    Clin Cancer Res; 2022 Jun; 28(11):2270-2277. PubMed ID: 35344029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics analyses of choroid plexus carcinoma cell lines reveal potential targetable pathways and alterations.
    Hesham D; On J; Alshahaby N; Amer N; Magdeldin S; Okada M; Tsukamoto Y; Hiraishi T; Imai C; Okuda S; Wakai T; Kakita A; Oishi M; El-Naggar S; Natsumeda M
    J Neurooncol; 2024 Jan; 166(1):27-38. PubMed ID: 38190092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of CDX2 expression in normal choroid plexus epithelium and choroid plexus tumors.
    Beschorner R; Mittelbronn M; Mugler M; Meyermann R; Schittenhelm J
    Histol Histopathol; 2009 Dec; 24(12):1507-14. PubMed ID: 19795349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
    Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
    J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
    Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
    Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic landscape of choroid plexus tumors in children and adults.
    Thomas C; Soschinski P; Zwaig M; Oikonomopoulos S; Okonechnikov K; Pajtler KW; Sill M; Schweizer L; Koch A; Neumann J; Schüller U; Sahm F; Rauschenbach L; Keyvani K; Proescholdt M; Riemenschneider MJ; Segewiß J; Ruckert C; Grauer O; Monoranu CM; Lamszus K; Patrizi A; Kordes U; Siebert R; Kool M; Ragoussis J; Foulkes WD; Paulus W; Rivera B; Hasselblatt M
    Neuro Oncol; 2021 Apr; 23(4):650-660. PubMed ID: 33249490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.